Last reviewed · How we verify

NCT04210076

Mindfulness Training for Small Teams

Completed NA Last updated 1 September 2022
What this trial tests

NA trial testing MBAT-T in Cognitive Change in 356 participants. Completed in 12 April 2022.

Timeline
10 May 2021
Primary endpoint
7 April 2022
12 April 2022

Quick facts

Lead sponsorUniversity of Miami
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment356
Start date10 May 2021
Primary completion7 April 2022
Estimated completion12 April 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Miami

Who can join

Adults 18 to 65, any sex, with Cognitive Change. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to look at how mindfulness training may influence how the participant thinks, feels, and acts.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Examining cognition in action: laboratory-based attentional control tasks predict performance on combat-relevant tasks in an augmented reality training environment.
    Zanesco AP, Denkova E, Barry J, Alessio C, et al · · 2025 · cited 1× · PMID 40391111 · DOI 10.3389/fpsyg.2025.1543161

Verify or expand the search:

Other recruiting trials for Cognitive Change

Currently open trials in the same condition.

Other University of Miami trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04210076.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing